LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,881 | +226.6% | 281,094 | +235.7% | 0.01% | +200.0% |
| Q2 2023 | $5,781 | -46.4% | 83,737 | -62.5% | 0.00% | -20.0% |
| Q1 2023 | $10,779 | -57.1% | 223,538 | -55.6% | 0.01% | -58.3% |
| Q4 2022 | $25,123 | -99.8% | 503,254 | +67.1% | 0.01% | -7.7% |
| Q3 2022 | $12,289,000 | -23.7% | 301,212 | +2.8% | 0.01% | +30.0% |
| Q2 2022 | $16,111,000 | +80.7% | 292,912 | +19.4% | 0.01% | +42.9% |
| Q1 2022 | $8,915,000 | – | 245,326 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |